Administrations have repeatedly tried to shine a bright light into the business practices of pharmacy benefit managers (PBMs). But those efforts have not been successful – until President Trump set his sights on lowering drug costs for the American worker. Thanks to his leadership, the Department of Labor is piercing the veil of secrecy that PBMs have hidden behind to introduce transparency in prescription drug pricing.
Read Full Article »
